Crossmark

Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

Published Online: 2016-12-01

Published Print: 2016-12

Authors

Marek-Trzonkowska, Natalia

Myśliwiec, Małgorzata

Iwaszkiewicz-Grześ, Dorota

Gliwiński, Mateusz

Derkowska, Ilona

Żalińska, Magdalena

Zieliński, Maciej

Grabowska, Marcelina

Zielińska, Hanna

Piekarska, Karolina

Jaźwińska-Curyłło, Anna

Owczuk, Radosław

Szadkowska, Agnieszka

Wyka, Krystyna

Witkowski, Piotr

Młynarski, Wojciech

Jarosz-Chobot, Przemysława

Bossowski, Artur

Siebert, Janusz

Trzonkowski, Piotr https://orcid.org/0000-0001-5287-5210
Clinical Trials ^BETA

Clinical trials referenced in this document:

isrctn06128462 at ISRCTN.org

Documents that mention this clinical trial

Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
https://doi.org/10.1186/s12967-016-1090-7
Funding

Funding for this research was provided by:

National Centre for Research and Development, Poland (STRATEGMED1/233368/1/NCBR/2014, LIDER/160/L-6/14/NCBR/2015)
License Information

Text and Data Mining valid from 2016-12-01

Version of Record valid from 2016-12-01
More Information

Article History

Received: 17 May 2016

Accepted: 22 November 2016

First Online: 1 December 2016

Document is current